Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.

Literature DB >> 21670187

In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.

Shawn R Lockhart¹, Alicia J Zimbeck, John W Baddley, Kieren A Marr, David R Andes, Thomas J Walsh, Carol A Kauffman, Dimitrios P Kontoyiannis, James I Ito, Peter G Pappas, Tom Chiller.

Abstract

We determined the echinocandin minimum effective concentration (MEC) values for caspofungin, micafungin, and anidulafungin against 288 Aspergillus isolates prospectively collected from transplant patients with proven or probable invasive aspergillosis between 2001 and 2006 as part of the Transplant-Associated Infection Surveillance Network (TRANSNET). We demonstrated that the vast majority of Aspergillus isolates had MEC values at or below the epidemiological cutoff values for caspofungin, micafungin, and anidulafungin, including those from patients who had received caspofungin.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2011 PMID： 21670187 PMCID： PMC3147660 DOI： 10.1128/AAC.00428-11

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

16 in total

1. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors: Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal: Clin Infect Dis Date: 2008-02-01 Impact factor: 9.079

Review 2. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.

Authors: Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal: Expert Rev Anti Infect Ther Date: 2010-03 Impact factor: 5.091

Review 3. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Authors: M A Pfaller; D Andes; D J Diekema; A Espinel-Ingroff; D Sheehan
Journal: Drug Resist Updat Date: 2010-11-02 Impact factor: 18.500

4. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Authors: Peter G Pappas; Barbara D Alexander; David R Andes; Susan Hadley; Carol A Kauffman; Alison Freifeld; Elias J Anaissie; Lisa M Brumble; Loreen Herwaldt; James Ito; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren A Marr; Vicki A Morrison; Benjamin J Park; Thomas F Patterson; Trish M Perl; Robert A Oster; Mindy G Schuster; Randall Walker; Thomas J Walsh; Kathleen A Wannemuehler; Tom M Chiller
Journal: Clin Infect Dis Date: 2010-04-15 Impact factor: 9.079

5. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors: S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal: Clin Infect Dis Date: 2001-11-26 Impact factor: 9.079

6. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.

Authors: M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal: J Clin Microbiol Date: 2009-08-26 Impact factor: 5.948

7. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.

Authors: John W Baddley; Kieren A Marr; David R Andes; Thomas J Walsh; Carol A Kauffman; Dimitrios P Kontoyiannis; James I Ito; S Arunmozhi Balajee; Peter G Pappas; Stephen A Moser
Journal: J Clin Microbiol Date: 2009-08-19 Impact factor: 5.948

8. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.

Authors: Adrienne Madureira; Anne Bergeron; Claire Lacroix; Marie Robin; Vanderson Rocha; Régis Peffault de Latour; Christèle Ferry; Agnès Devergie; Jordane Lapalu; Eliane Gluckmana; Gérard Socié; Mahmoud Ghannoum; Patricia Ribaud
Journal: Int J Antimicrob Agents Date: 2007-12 Impact factor: 5.283

9. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.

Authors: Laura Alcazar-Fuoli; Emilia Mellado; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2008-01-22 Impact factor: 5.191

10. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.

Authors: S Arunmozhi Balajee; Rui Kano; John W Baddley; Stephen A Moser; Kieren A Marr; Barbara D Alexander; David Andes; Dimitrios P Kontoyiannis; Giancarlo Perrone; Stephen Peterson; Mary E Brandt; Peter G Pappas; Tom Chiller
Journal: J Clin Microbiol Date: 2009-08-12 Impact factor: 5.948

15 in total

Review 1. Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.

Authors: Marion Aruanno; Emmanouil Glampedakis; Frédéric Lamoth
Journal: Antimicrob Agents Chemother Date: 2019-07-25 Impact factor: 5.191

2. Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.

Authors: Mojtaba Taghizadeh-Armaki; Mohammad Taghi Hedayati; Saham Ansari; Saeed Mahdavi Omran; Sasan Saber; Haleh Rafati; Jan Zoll; Henrich A van der Lee; Willem J G Melchers; Paul E Verweij; Seyedmojtaba Seyedmousavi
Journal: Antimicrob Agents Chemother Date: 2017-04-24 Impact factor: 5.191

3. Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, India.

Authors: Aradhana Masih; Pradeep K Singh; Shallu Kathuria; Kshitij Agarwal; Jacques F Meis; Anuradha Chowdhary
Journal: J Clin Microbiol Date: 2016-07-13 Impact factor: 5.948

4. Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

Authors: Joseph Meletiadis; Maria Siopi; Lamprini Kanioura; Karin Meinike Jørgensen; David S Perlin; Johan W Mouton; Maiken Cavling Arendrup
Journal: J Antimicrob Chemother Date: 2019-08-01 Impact factor: 5.790

5. Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.

Authors: Maria Siopi; Spyros Pournaras; Joseph Meletiadis
Journal: J Clin Microbiol Date: 2017-03-22 Impact factor: 5.948

6. Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections.

Authors: J A Olson; J Schwartz; D Hahka; A George; R T Proffitt; J P Adler-Moore
Journal: Antimicrob Agents Chemother Date: 2011-10-03 Impact factor: 5.191

7. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.

Authors: M G Vossen; D Knafl; M Haidinger; R Lemmerer; M Unger; S Pferschy; W Lamm; A Maier-Salamon; W Jäger; F Thalhammer
Journal: Antimicrob Agents Chemother Date: 2017-07-25 Impact factor: 5.191

8. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.

Authors: Masato Tashiro; Koichi Izumikawa; Asuka Minematsu; Katsuji Hirano; Naoki Iwanaga; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal: Antimicrob Agents Chemother Date: 2011-10-24 Impact factor: 5.191

9. An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus.

Authors: Cau D Pham; Shawn R Lockhart
Journal: Curr Fungal Infect Rep Date: 2012-12-16

10. A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method.